Overview

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate changes in tumor blood flow and disease response to the investigation agent, 177Lu-J591.
Phase:
Phase 1
Details
Lead Sponsor:
Weill Medical College of Cornell University
Treatments:
Antibodies
Antibodies, Monoclonal
Immunoglobulins